Literature DB >> 8432821

An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.

B Wilske1, V Preac-Mursic, U B Göbel, B Graf, S Jauris, E Soutschek, E Schwab, G Zumstein.   

Abstract

A total of 136 Borrelia burgdorferi sensu latu strains from various biological sources (ticks, human skin, and cerebrospinal fluid) and geographical sources (Europe and North America) were investigated by Western blot (immunoblot) with eight monoclonal antibodies against different epitopes of the outer surface protein A (OspA). On the basis of the differential reactivities of these monoclonal antibodies, seven OspA serotypes were defined. As determined by 16S rRNA sequence analysis, these serotypes correlated well with recently delineated genospecies: serotype 1 corresponds to B. burgdorferi sensu strictu, serotype 2 corresponds to group VS461, and serotypes 3 to 7 correspond to Borrelia garinii sp. nov. (G. Baranton, D. Postic, I. Saint Girons, P. Boerlin, J.-C. Piffaretti, M. Assous, and P. A. D. Grimont, Int. J. Syst. Bacteriol. 42:378-383, 1992). Antigenic differences were confirmed by partial sequence analysis of OspA of representatives of each serotype. Comparative sequence analysis suggested that serotype 5 OspA resulted from genetic recombination of serotype 4 and 6 ospA genes. Serotype 2 (group VS461) was most prevalent among European skin isolates (49 of 62 isolates). Among all B. garinii strains included in this study, serotype 6 was most frequently found in ticks and only rarely in human skin and cerebrospinal fluid, whereas serotypes 4 and 5 were isolated from patients but never from ticks. Our data suggest different pathogenic potentials and organotropisms of distinct OspA serotypes and raise the question of true antigenic variation among B. garinii strains.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432821      PMCID: PMC262762          DOI: 10.1128/jcm.31.2.340-350.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  50 in total

1.  Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.

Authors:  E Fikrig; S W Barthold; F S Kantor; R A Flavell
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

2.  Linear- and circular-plasmid copy numbers in Borrelia burgdorferi.

Authors:  J Hinnebusch; A G Barbour
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

3.  Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates.

Authors:  A G Barbour; R A Heiland; T R Howe
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

4.  Antigenic heterogeneity of European Borrelia burgdorferi strains isolated from patients and ticks.

Authors:  B Wilske; V Preac-Mursic; G Schierz
Journal:  Lancet       Date:  1985-05-11       Impact factor: 79.321

Review 5.  The global distribution of Lyme disease.

Authors:  G P Schmid
Journal:  Rev Infect Dis       Date:  1985 Jan-Feb

6.  Variation in a major surface protein of Lyme disease spirochetes.

Authors:  A G Barbour; S L Tessier; S F Hayes
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

7.  Lyme disease in California: a novel enzootic transmission cycle of Borrelia burgdorferi.

Authors:  R N Brown; R S Lane
Journal:  Science       Date:  1992-06-05       Impact factor: 47.728

8.  Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

Authors:  G Baranton; D Postic; I Saint Girons; P Boerlin; J C Piffaretti; M Assous; P A Grimont
Journal:  Int J Syst Bacteriol       Date:  1992-07

9.  Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients.

Authors:  E Asbrink; A Hovmark; I Olsson
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-12

10.  [Clinical aspects and etiology of acrodermatitis chronica atrophicans].

Authors:  K Weber; G Schierz; B Wilske; V Preac-Mursic
Journal:  Hautarzt       Date:  1984-11       Impact factor: 0.751

View more
  131 in total

1.  Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe.

Authors:  U Hauser; G Lehnert; B Wilske
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Spirochetal non-Borrelia-microorganism isolated from Ixodes ricinus.

Authors:  K Schwarzová; I Ciznár
Journal:  Folia Microbiol (Praha)       Date:  1996       Impact factor: 2.099

3.  Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens.

Authors:  D Liveris; S Varde; R Iyer; S Koenig; S Bittker; D Cooper; D McKenna; J Nowakowski; R B Nadelman; G P Wormser; I Schwartz
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

4.  A 55-kilodalton antigen encoded by a gene on a Borrelia burgdorferi 49-kilobase plasmid is recognized by antibodies in sera from patients with Lyme disease.

Authors:  S Feng; S Das; T Lam; R A Flavell; E Fikrig
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Evaluation of the polymerase chain reaction for the detection of Borrelia burgdorferi in cerebrospinal fluid of children with acute peripheral facial palsy.

Authors:  H J Christen; H Eiffert; A Ohlenbusch; F Hanefeld
Journal:  Eur J Pediatr       Date:  1995-05       Impact factor: 3.183

6.  Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.

Authors:  Y F Chang; M J Appel; R H Jacobson; S J Shin; P Harpending; R Straubinger; L A Patrican; H Mohammed; B A Summers
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Taxonomic classification of 29 Borrelia burgdorferi strains isolated from patients with Lyme borreliosis: a comparison of five different phenotypic and genotypic typing schemes.

Authors:  A M Lebech; K Hansen; B Wilske; M Theisen
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

8.  Use of polymerase chain reaction and specific monoclonal antibodies as rapid method to recognize Borrelia burgdorferi sensu stricto, B. garinii and B. afzelii among Italian isolates of B. burgdorferi.

Authors:  M Cinco; C Costantini; B Wilske; G Graziosi; G Trevisan; F Florian
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

9.  Detection and molecular typing of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks and in different patient samples from southwest Germany.

Authors:  D Schaarschmidt; R Oehme; P Kimmig; R D Hesch; S Englisch
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

10.  Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany.

Authors:  B Wilske; U Busch; H Eiffert; V Fingerle; H W Pfister; D Rössler; V Preac-Mursic
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.